فهرست:
فصل اول : مقدمه
1-1- بیان مسئله.. 2
1-2- کلیات.. 5
1-2-1- پلاکت... 5
1-2-2- ترومبوسیتوپنی.. 6
1-2-3- رویکرد به بیمار ترومبوسیتوپنی.. 7
1-2-4- ترومبوسیتوپنی ناشی از عفونت... 9
1-2-5- ترومبوسیتوپنی ناشی از دارو. 10
1-2-6- پورپورای ایمنی ترومبوسیتوپنیک (ITP) 10
1-2-7- علائم ITP.. 11
1-2-8- تشخیص ITP.. 12
1-2-9- درمان ITP.. 13
1-2-9-1- انتخاب بیماران. 15
1-2-9-2- گلوکوکورتیکوئیدها 17
1-2-9-3- روگام. 17
1-2-9-4- IV IgG... 17
1-2-9-5-رتیوکسی ماب.. 18
1-2-9-6- اسپلنکتومی.. 18
1-2-9-7- آگونیست گیرنده TPO... 18
1-2-10- پردنیزولون. 19
1-2-10-1- موارد استفاده. 20
1-2-10-2- عوارض جانبی پردنیزولون. 21
1-2-10-3- کنتراندیکاسیونهای پردنیزولون. 22
1-2-10-4- تداخلات.. 22
1-3- اهداف... 23
1-3-1- هدف اصلی.. 23
1-3-2- اهداف ویژه. 23
1-3-3- اهداف کاربردی.. 23
1-4- سئوالات.. 24
1-5- فرضیات.. 24
1-6- تعریف واژه‌ها 25
فصل دوم : بررسی متون
2-1- مروری بر مطالعات انجام شده. 28
فصل سوم : مواد و روش کار
3-1- نوع مطالعه و جامعه مورد آزمون... 34
3-2- روش نمونه گیری.. 34
3-3- زمان و مکان مطالعه.. 35
3-4- روش و تکنیک کار 36
3-5- مشکلات و محدودیتها 37
3-6- راه حل رفع مشکلات.. 37
3-7- روش آماری و تجزیه و تحلیل اطلاعات.. 37
3-8- جدول متغیرها 38
3-9- ملاحظات اخلاقی.. 39
فصل چهارم : یافته‌ها
4-1- نتایج... 41
4-2- جداول.. 44
فصل پنجم : بحث و نتیجه‌گیری
5-2- نتیجه گیری.. 50
5-3- پیشنهادات.. 51
منبع:
Reference:
Georg, JN, Woolf , SH, Raskob , GE, et al. Idiopathic thrombocytopenic purpura : A practice developed by explicit methods for the American society of Hematology. Blood 1996 ; 88 : 3.
Clines , DB Blanchette , VS. Immune thrombocytopenic purpura. N Engl J Med 2002 ; 346 : 995.
Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy, Br J Haematol 2003 ; 120 : 574.
Rodeghiero , F , stasi , R , Gernsheimer , T, et al. standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children : report from an international working group. Blood 2009 ; 113 : 2386.
Provan , D, Stasi , R, Newland , AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010 ; 115 : 168.
Cines , DB, Bussel , JB, Liebman , HA, Luning Prak , ET. The ITP syndrome : pathogenic and clinical diversity. Blood 2009 ; 113 : 6511.
Cooper , N, Bussel , J. The pathogenesis of immune thrombocytopenic purpura. Br J Haematol 2006 ; 133 : 364.
Sood , R, Wong , W, Gotlib , J, et al. Gene expression and pathway analysis of immune thrombocytopenic purpura. Br J Haematol 2008 ; 140 : 990.
Dimaggio, D, Anderson, A, Bussel , JB. Cytomegalovirus can make immune thrombocytopenic pupura refractory, Br J Haematol 2009 ; 146 : 104.
Zeller , B, Rarjantie, J, Hedlund – Treutiger, I , et al. Childhood idiopathic thrombocytopenic purpura in the Nordic countries : epidemiology and predictors of chronic disease. Acta paediatr 2005 ; 94 : 178.
Frederiksen , H, Schmidt , K. The incidence of idiopathic purpura in adults increases with age. Blood 1999 ; 94 : 909.
Marieke schoonen , W, Kucera, G , Coalson , J , et al. Epidemiology of immune thrombocytopenic purpura in the general practice research database. Br J Haematol 2009 ; 145 : 235.
Watts RG (2004) "Idiopathic thrombocytopenic purpura : a 10 year natural history study at the childrens hospital of Alabama" . clinical pediatrics 43(8) : 691-702. dio : 10.1177/0009922 80404300802 . PMID 15494875.
Cortelazzo , S, Finazzi , G, Buelli , M, et al. High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood 1991 ; 77 : 31.
Guthrie , TH, Brannan , DP, Prisant , LM. Idiopathic thrombocytopenic purpura in the older adult patients. Am J Med sci 1988 ; 296 : 17.
Pegels , JG, Bruynes , ECE , Engelfriet , CP , von dem Borne , AE. Pseudothrombocytopenia : An immunologic study on platelet antibodies dependent of ethylene diamine tetra-acetate. Blood 1982 ; 59 : 157.
Stasi , R, Stipa , E , Masi , M , et al. Long – term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J med 1995 ; 98 : 436.
Rodeghlero F. Idiopathic thrombocytopenic purpura : An old disease revisited in the eva of evidence – based medicine. Haematologica. 2003 ; 88(10) : 1081-1087.
Stasi R, et al. Management of Immune thrombocytopenic purpura in adult. Mayo clinic proceeding. 2004 ; 79(4) : 504-522.
George JN, Woolf SH, et al. Idiopathic thrombocytopenic purpura : a practice guidelines developed by explicit methods for the American society of Haematology. Blood 1996 ; 88 : 3 -40.
Mc Dougall , R, Sibley , J, Haga, M,et al. outcome in patients with rheumatoid arthritis receiving prednisone compared to matched controls. J Rheumatol 1994 ; 21 : 1207.
Fauci , AS, Dale , DC, Balow , JE. Glucoglucocorticoid thevapy : mechanisms of action and clinical considerations. Ann Intern Med 1976 ; 84 : 304.
Laurie Barclay MD. "4-Day course of High – Dose Dexamethasone May Be Effective in ITP" . N Engl J Med. 2003 : 349 : 831-836, 903-905.
Portielje , JE, Westendorp, RG, Kluin-Nelemans , HC, Brand , A. Morbidity and Mortality in adults with idiopathic thrombocytopenic purpura. Blood 2001 ; 97 : 2549.
Neglon , Saunders , PW, Howard, MR, et al. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adalts : a prospective study of a population based cohort of 245 patients. Br J Haematol 2003 ; 122 : 966.
Cines , DB Bussel , JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood 2005 ; 106 : 2244.
Slichter, SL, Harker , LA. Thrombocytopenia : Mechanisms and managemenf of defects in platelet production. Clin haematol 1978 : 7 : 523.
Wandt H, Frank , M, Ehninger , G , et al. Safety and cost effectiveness of a 10x10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20x10(9)/L trigger : A prospective comparative trial in 105 patients with acute myeloid leukemia. Blood 1998 ; 91 : 3601.
Lacey , JV, Penner , JA. Management of idiopathic thrombocytopenic purpura in the adalts. Semin thromb hemost 1977 ; 3 : 160.
Guidry, JA, George , JN, Vesely , SK, et al. Corticosteroid side – effects and risk for bleeding in immune thrombocytopenic purpura : patient and hematologist perspectives. Eur J Haematol 2009 ; 83 : 175.
Cheng, Y, Wong, RS, Soo, Yo, et al. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethazone. N Engl J Med 2003 ; 349-831.
Borst, F, Keuning , JJ, Van Hulsteigin , H et al. High – dose dekamethazone as a first-and second – line treatment of idiopathic thrombocytopenic purpura in adults. Ann Hematol 2004 : 83 : 764.
Mazzucconi , MG, Fazi , P, Bernasconi , S, et al. Therapy with high-dose dexamethazone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura : a GIMEMA experience . Blood 2007; 109 : 1401.